Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-29.93%
↓ 404% below average
Average (38q)
9.84%
Historical baseline
Range
High:639.04%
Low:-597.40%
Volatility
12570.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -29.93% |
| Q2 2025 | 601.66% |
| Q1 2025 | -73.29% |
| Q4 2024 | -52.76% |
| Q3 2024 | 25.51% |
| Q2 2024 | 54.80% |
| Q1 2024 | 114.72% |
| Q4 2023 | -69.71% |
| Q3 2023 | -597.40% |
| Q2 2023 | 639.04% |
| Q1 2023 | 102.37% |
| Q4 2022 | -5.26% |
| Q3 2022 | 21.57% |
| Q2 2022 | -5.33% |
| Q1 2022 | -179.76% |
| Q4 2021 | 63.49% |
| Q3 2021 | -47.65% |
| Q2 2021 | 27.11% |
| Q1 2021 | -9.76% |
| Q4 2020 | -10.50% |
| Q3 2020 | 3.28% |
| Q2 2020 | 21.79% |
| Q1 2020 | -52.25% |
| Q4 2019 | -36.99% |
| Q3 2019 | 25.71% |
| Q2 2019 | 27.20% |
| Q1 2019 | -22.96% |
| Q4 2018 | 34.18% |
| Q3 2018 | -88.17% |
| Q2 2018 | 9.92% |
| Q1 2018 | 35.48% |
| Q4 2017 | -125.37% |
| Q3 2017 | -17.12% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |